Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Microsatellite Instability × Disulfides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2 Stroke 1 Sarcoma 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Microsatellite Instability 1 Lymphoma 1 Kidney Failure, Chronic 1 Diabetes Mellitus 1 Coronary Artery Disease 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1 Breast Neoplasms 1

Interventions

durvalumab 1 Immunoglobulin G 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02966587 2018-01-17

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

University of Washington

Phase 2 Withdrawn

Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡